“This indicates that several signal substances are implicated in ADHD and that in the future this could pave the way for other drugs than those in use today,” says Jessica Johansson, who is presenting her research findings in a dissertation in medicine at Örebro University.
Jessica Johansson belongs to the Experimental Neuropsychiatric research group that has mapped part of the biochemical changes in cells that underlie ADHD and other neuropsychiatric functional impairments and disorders. Head of the group is Nikolaos Venizelos.
“I usually say that I’m doing research on mental diseases and functional impairments at the cellular level. Many of these are assumed to be the consequence of excessively low levels of important signal substances in the brain, so cell biochemical analyses help us understand the processes that cause the changes.”
For the brain to be able to produce the substances required to send signals, it is dependent on various amino acids being transported to the brain. When it comes to ADHD, Jessica Johansson has studied the transport of amino acids tyrosine and tryptophan, which the brain uses in producing the signal substances dopamine, noradrenaline, and serotonin.
By analyzing a certain type of connective tissue cells’ (so-called fibroblasts’) capacity to transport these substances, the researchers can also reach conclusions about how well the transport into the brain is working. The findings from these studies show that the transport of tryptophan is lower in children with ADHD, compared with children without that diagnosis.
“This probably means that the brain produces less serotonin. Thus far the focus has mainly been on the signal substances dopamine and noradrenaline in the medical treatment of ADHD. But if low levels of serotonin are also a contributing factor, other drugs may be necessary for successful treatment.”
The head of the research group Nikolaos Venizelos says that the most unexpected discovery in the study, however, was the dramatically reduced amount of the so-called acetylcholine receptor in children with ADHD says. It functions as a receptor protein for the signal substance acetylcholine and is therefore necessary for key signals involving concentration and learning functions, for example. Drugs that reinforce the acetylcholine effect are used in treating Alzheimer’s patients, for instance.
Jessica Johansson has also studied biochemical changes in bipolar disorder (previously called manic-depressive disorder), as there are parallels between ADHD and bipolar disorder. Here it was instead the transport of the amino acid tyrosine that was disturbed, which indicates a reduced production of the signal substances dopamine and noradrenaline.
“Since we have previously seen the same thing in patients with schizophrenia, it’s an indication that both disorders have the same deviant amino acid transport, which might be caused by a shared genetic variant.”For more information, please contact: Jessica Johansson cell phone: +46 (0)707-31 01 43, email@example.com or
Assoc Professor Nikolaos Venizelos, cell phone: + 46 (0)702 55 85 20, firstname.lastname@example.org.
Ingrid Lundegårdh | idw
Cancer diagnosis: no more needles?
25.05.2018 | Christian-Albrechts-Universität zu Kiel
Less is more? Gene switch for healthy aging found
25.05.2018 | Leibniz-Institut für Alternsforschung - Fritz-Lipmann-Institut e.V. (FLI)
The more electronics steer, accelerate and brake cars, the more important it is to protect them against cyber-attacks. That is why 15 partners from industry and academia will work together over the next three years on new approaches to IT security in self-driving cars. The joint project goes by the name Security For Connected, Autonomous Cars (SecForCARs) and has funding of €7.2 million from the German Federal Ministry of Education and Research. Infineon is leading the project.
Vehicles already offer diverse communication interfaces and more and more automated functions, such as distance and lane-keeping assist systems. At the same...
A research team led by physicists at the Technical University of Munich (TUM) has developed molecular nanoswitches that can be toggled between two structurally different states using an applied voltage. They can serve as the basis for a pioneering class of devices that could replace silicon-based components with organic molecules.
The development of new electronic technologies drives the incessant reduction of functional component sizes. In the context of an international collaborative...
At the LASYS 2018, from June 5th to 7th, the Laser Zentrum Hannover e.V. (LZH) will be showcasing processes for the laser material processing of tomorrow in hall 4 at stand 4E75. With blown bomb shells the LZH will present first results of a research project on civil security.
At this year's LASYS, the LZH will exhibit light-based processes such as cutting, welding, ablation and structuring as well as additive manufacturing for...
There are videos on the internet that can make one marvel at technology. For example, a smartphone is casually bent around the arm or a thin-film display is rolled in all directions and with almost every diameter. From the user's point of view, this looks fantastic. From a professional point of view, however, the question arises: Is that already possible?
At Display Week 2018, scientists from the Fraunhofer Institute for Applied Polymer Research IAP will be demonstrating today’s technological possibilities and...
So-called quantum many-body scars allow quantum systems to stay out of equilibrium much longer, explaining experiment | Study published in Nature Physics
Recently, researchers from Harvard and MIT succeeded in trapping a record 53 atoms and individually controlling their quantum state, realizing what is called a...
25.05.2018 | Event News
02.05.2018 | Event News
13.04.2018 | Event News
25.05.2018 | Event News
25.05.2018 | Machine Engineering
25.05.2018 | Life Sciences